当前位置: 首页 > 期刊 > 《中外健康文摘·新医学学刊》 > 2008年第2期
编号:11629036
脑利尿钠肽在心血管病中的研究进展(3)
http://www.100md.com 2008年2月1日 《中外健康文摘·新医学学刊》 2008年第2期
     [13] Nagaya N,Goto Y,Nishikimi T,et a1.Sustained elevation of plasma brain natriuretic peptide levels associated with progressive ventficular remodeling after acute myocardial infaretion[J].Clinical Science,1999,96:129-136

    [14] Suzuki M,Hamada M,Yamamoto K,et al. a1.Brain natriuretic peptide as a risk marker for incident hypertensive cardiovascular event~[J].Hypertens Res,20O2,25(5):669~676

    [15] Kario K,Nishikimi T,Yoshihara F,et a1.Plasma levels of natriuretic peptide and adrenomedullin in elderly hypertension patients:Relationships to 24h blood pressure[J].J Hypertens,1998:16(9):1253~125

    [16] The Framingham Heart Study.Plasma natriuretic peptide for community screening for left ventricular hypertrophy and systolic dysfunction[J].JAMA,2002,288:1252-1259

    [17] VMAC Investigators.Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure:a randomized controlled tria1.JAMA,2002,287:1531-1540

    [18] Burger A,Deaconess B.Nesiritide is not associated with the proarrhythmic efects of dobutamine in treatment of decompensated CHF:the Precedent Study. Circulation,1999,100:647

    [19] Marcus L,Hart D.Hemodynamic and renal excretory efects of human BNP infusion in patients with congestive heart failure. Circu1ation,1996,94:3184-3189

    , http://www.100md.com(黄於娟)
上一页1 2 3